CA1002049A - 3,5-dioxopiperazinyl derivatives - Google Patents

3,5-dioxopiperazinyl derivatives

Info

Publication number
CA1002049A
CA1002049A CA130,520A CA130520A CA1002049A CA 1002049 A CA1002049 A CA 1002049A CA 130520 A CA130520 A CA 130520A CA 1002049 A CA1002049 A CA 1002049A
Authority
CA
Canada
Prior art keywords
dioxopiperazinyl
derivatives
dioxopiperazinyl derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA130,520A
Other languages
English (en)
Other versions
CA130520S (en
Inventor
Andrew M. Dreighton
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
National Research Development Corp UK
Original Assignee
National Research Development Corp UK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by National Research Development Corp UK filed Critical National Research Development Corp UK
Application granted granted Critical
Publication of CA1002049A publication Critical patent/CA1002049A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C247/00—Compounds containing azido groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C243/00—Compounds containing chains of nitrogen atoms singly-bound to each other, e.g. hydrazines, triazanes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/20—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by nitrogen atoms not being part of nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/09—Preparation of carboxylic acids or their salts, halides or anhydrides from carboxylic acid esters or lactones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/06—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members
    • C07D241/08—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
CA130,520A 1970-12-21 1971-12-20 3,5-dioxopiperazinyl derivatives Expired CA1002049A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB6056470A GB1374979A (en) 1970-12-21 1970-12-21 3,5-dioxopiperazine derivatives
GB710071 1971-03-17

Publications (1)

Publication Number Publication Date
CA1002049A true CA1002049A (en) 1976-12-21

Family

ID=26241204

Family Applications (1)

Application Number Title Priority Date Filing Date
CA130,520A Expired CA1002049A (en) 1970-12-21 1971-12-20 3,5-dioxopiperazinyl derivatives

Country Status (9)

Country Link
AU (1) AU470566B2 (en, 2012)
BE (1) BE776958R (en, 2012)
CA (1) CA1002049A (en, 2012)
CH (3) CH563997A5 (en, 2012)
DE (1) DE2163601A1 (en, 2012)
FR (1) FR2154389B2 (en, 2012)
GB (1) GB1374979A (en, 2012)
IL (1) IL38342A (en, 2012)
SE (1) SE400286B (en, 2012)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3324235A1 (de) * 1983-07-01 1985-01-10 Schering AG, 1000 Berlin und 4709 Bergkamen Neue komplexbildner, komplexe und komplexsalze
US5162372A (en) * 1985-04-01 1992-11-10 National Research Development Corporation Pharmaceutical compositions for treating certain cancers
US5278187A (en) * 1985-04-01 1994-01-11 British Technology Group Ltd. Pharmaceutical compositions
US5149710A (en) * 1985-04-01 1992-09-22 National Research Development Corporation Pharmaceutical compositions for treating psoriasis
GB8508508D0 (en) * 1985-04-01 1985-05-09 Creighton A M Pharmaceutical compositions
US5693309A (en) * 1987-03-31 1997-12-02 Schering Aktiengesellschaft Substituted complexing agents, complexes, and complex salts, processes for their production, and pharmaceuticals containing same
US5482700A (en) * 1987-03-31 1996-01-09 Schering Aktiengesellschaft Substituted polyamino, polycarboxy complexing agent dimers for MRI and X-ray contrast
DE3710730A1 (de) * 1987-03-31 1988-10-20 Schering Ag Substituierte komplexbildner, komplexe und komplexsalze, verfahren zu deren herstellung und diese enthaltende pharmazeutische mittel
US5399340A (en) * 1987-09-24 1995-03-21 Schering Aktiengesellschaft Use of amide complex compounds
US4963679A (en) * 1988-02-17 1990-10-16 Erbamont, Inc. Process for preparing bis (3,5-dioxopiperazinyl) alkanes or alkenes
GB2229362A (en) * 1989-01-31 1990-09-26 Kurt Hellmann Radiosensitising compositions comprising a razoxane optical isomer
US6039931A (en) * 1989-06-30 2000-03-21 Schering Aktiengesellschaft Derivatized DTPA complexes, pharmaceutical agents containing these compounds, their use, and processes for their production
US5695739A (en) * 1989-06-30 1997-12-09 Schering Aktiengesellschaft Derivatized DTPA complexes, pharmaceutical agents containing these compounds, their use, and processes for their production
GB8916072D0 (en) * 1989-07-13 1989-08-31 Creighton Andrew M Pharmaceutical compositions
GB9115596D0 (en) * 1991-07-12 1991-09-04 Creighton Andrew M Pharmaceutical compositions
GB9124483D0 (en) * 1991-11-18 1992-01-08 Windleshaw Enterprises Ltd Bis(3,5-dioxoalkylpiperazine)derivatives for use in treating intracellular accumulation of metal ions
US5672335A (en) * 1994-11-30 1997-09-30 Schering Aktiengesellschaft Use of metal complexes as liver and gallbladder X-ray diagnostic agents
US6265385B1 (en) * 1996-01-11 2001-07-24 Topo Target Aps Topoisomerase II poison and bis-dioxopiperazine derivative combination therapy

Also Published As

Publication number Publication date
SE400286B (sv) 1978-03-20
BE776958R (fr) 1972-06-20
GB1374979A (en) 1974-11-20
AU3683771A (en) 1973-06-21
AU470566B2 (en) 1976-03-18
FR2154389A2 (en, 2012) 1973-05-11
IL38342A (en) 1978-03-10
FR2154389B2 (en, 2012) 1975-11-28
CH563996A5 (en, 2012) 1975-07-15
CH564541A5 (en, 2012) 1975-07-31
DE2163601A1 (de) 1972-06-22
CH563997A5 (en, 2012) 1975-07-15

Similar Documents

Publication Publication Date Title
IL37825A (en) 1-phenyl-8-chloro-2,3,4-5-tetrahydro-1h-1,5-benzodiazepin-2-one derivatives
AU470566B2 (en) 3, 5-dioxopiperazine derivatives
CA965104A (en) 3,4,5-trialkylcyclohexanols
AU465145B2 (en) 2, 4-diamino-5-benzylpyrimidines
CA943126A (en) 4,14-estradiene compounds
CA928710A (en) 1,2,3,4-tetrahydroisoquinoline derivatives
CA837636A (en) 1,3-diazacyclo-2,4-butanediones
CA948215A (en) Derivatives of 1,2-diphenyl-ethane
CA838136A (en) 1,2-dihydro-1-hydroxy-2-imino-6-lower alkylpyrimidine derivatives
CA838144A (en) 1,2-dihydro-1-hydroxy-2-imino-4-phenoxypyrimidine derivatives
CA843941A (en) 9,10-dihydro-anthrol derivatives
CA834198A (en) Benzoxazolyl-1,3,4-oxdiazole derivatives
CA838135A (en) 1,2-dihydro-1-hydroxy-2-imino-6-lower alkylpyrimidine derivatives
CA833560A (en) 1,2-dihydro-1-hydroxy-2-imino-5-aminopyrimidine derivatives
CA838137A (en) 1,2-dihydro-1-hydroxy-2-imino-5-nitro-pyrimidine derivatives
AU3151271A (en) Substituted 1, 3-indandiols
CA858562A (en) 2-halo-3,11,20-triketo-17-hydroxy-21-acyloxy-pregnanes
CA831547A (en) 2,6-diarylphenols
CA854718A (en) 1,2-dihydro-1-hydroxypyrimidines
CA854194A (en) 2,3,1-diazaborines
CA851181A (en) 2,2-ethylenetestosterones
CA838693A (en) 1,2-dihydro-1-hydroxypyrimidines
CA839720A (en) 2-aryl-1-oxa-3-azaspiro (5,5) undec-2-enes
AU464322B2 (en) 4, 14-estradiene compounds
AU440569B2 (en) 1,2,6b,7b-DIMETHYLENE-STEROIDS